Search

Search Constraints

You searched for: Author/Creator Koeppe, Robert A.

Search Results

1. 18F-florbetapir Positron Emission Tomography–determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. (April 2018)

2. [IC‐P‐054]: EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: RESULTS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK. (1st July 2017)

3. [IC‐P‐166]: UTILITY OF PERFUSION PET MODELS AS MEASURE OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY. (1st July 2017)

4. [O1–02–03]: EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: FINDINGS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK. (1st July 2017)

5. [P2–372]: UTILITY OF PERFUSION PET MODELS AS MEASURES OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY. (1st July 2017)

6. AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains. (20th December 2022)

7. AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains. (20th December 2022)

8. Amyloid and tau PET in sporadic early‐onset Alzheimer's disease: Preliminary results from LEADS: LEADS: Sporadic early‐onset Alzheimer's disease in the spotlight. (7th December 2020)

9. An updated synthesis of [11C]carfentanil for positron emission tomography (PET) imaging of the μ‐opioid receptor. (12th May 2017)

10. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Issue 12 (7th May 2015)